Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Pharmacogenetics of Drug Metabolism: Overview

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...

Post-traumatic Stress Disorder

Post-traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events, are a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Establishment of A Mouse Sepsis-Induced Immunosuppression Model By Intranasal Instillation of Bacteria.

Journal of visualized experiments : JoVE·2026

Same author

Targeting a conserved flagellin D1 epitope with 16G10 confers cross-serotype protection in murine <i>Pseudomonas aeruginosa</i> infection models.

Human vaccines & immunotherapeutics·2026

Same author

Beyond DNA editing: how Cas13 redefined programmable RNA manipulation and what still limits its therapeutic promise.

Nucleic acids research·2026

Same author

Immune cells with senescence-related transcriptional signatures orchestrate the inflammatory continuum in osteoarthritis synovium: a single-cell and machine learning study.

Frontiers in immunology·2026

Same author

Mini-Catalytically Inactive Cas13X-Derived RNA Base Editing of β-Catenin Attenuates Pulmonary Damage in a Murine Acute Lung Injury Model.

MedComm·2026

Same author

Preparation, antioxidant and immunomodulatory activities of selenium-modified galactomannan.

Food chemistry·2026

Same journal

Screen for Footprints of Selection during Domestication/Captive Breeding of Atlantic Salmon.

Comparative and functional genomics·2013

Same journal

Gemi: PCR primers prediction from multiple alignments.

Comparative and functional genomics·2013

Same journal

TnpPred: A Web Service for the Robust Prediction of Prokaryotic Transposases.

Comparative and functional genomics·2012

Same journal

The α(1)AT and TIMP-1 Gene Polymorphism in the Development of Asthma.

Comparative and functional genomics·2012

Same journal

Comparative Analysis of MicroRNAs between Sporophyte and Gametophyte of Porphyra yezoensis.

Comparative and functional genomics·2012

Same journal

Correlation of aquaporins and transmembrane solute transporters revealed by genome-wide analysis in developing maize leaf.

Comparative and functional genomics·2012

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting

Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting

Published on: November 30, 2015

Genetic polymorphisms and posttraumatic complications.

Wei Gu¹, Jianxin Jiang

¹State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Surgery Research, Chongqing 400042, China.

Comparative and Functional Genomics

|January 29, 2011

Summary

This summary is machine-generated.

Major trauma remains a leading cause of death, with complications like sepsis and multiple organ dysfunction syndrome (MODS) posing significant risks. Genetic variations, particularly single nucleotide polymorphisms (SNPs), may offer insights into predicting and managing these severe post-injury outcomes.

Related Experiment Videos

Last Updated: Jun 4, 2026

Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting

Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting

Published on: November 30, 2015

Area of Science:

Trauma and Emergency Medicine
Genetics and Genomics
Immunology

Background:

Major trauma is a primary cause of mortality in young adults, with survival rates stagnating despite medical advancements.
Severe trauma survivors face high risks of life-threatening complications such as sepsis and multiple organ dysfunction syndrome (MODS).
Genetic factors, specifically single nucleotide polymorphisms (SNPs), are increasingly recognized for their role in disease susceptibility and progression.

Purpose of the Study:

To explore the role of genetic polymorphisms in the development of post-traumatic complications.
To summarize recent findings on genetic variations in innate immunity and other systems linked to trauma outcomes.
To highlight the potential of genetic polymorphisms as biomarkers for diagnosing and prognosing trauma-induced complications.

Main Methods:

Review of recent scientific literature on genetic variations and post-traumatic complications.
Focus on studies investigating single nucleotide polymorphisms (SNPs) in relation to sepsis and MODS.
Analysis of genetic polymorphisms in innate immune system molecules and other relevant systems.

Main Results:

Evidence suggests genetic backgrounds significantly influence susceptibility to post-traumatic complications.
Specific genetic polymorphisms are associated with increased risk for sepsis and MODS following major trauma.
Genetic variations offer potential as predictive biomarkers for trauma outcomes.

Conclusions:

Genetic polymorphisms play a crucial role in the development of post-traumatic complications like sepsis and MODS.
Understanding these genetic factors can lead to improved diagnostic and prognostic tools for trauma patients.
Further research into genetic variations holds promise for personalized trauma care strategies.